Exchange Scholar Program UTSW and the 1st Affiliated Hospital of SYSU Trainee: Dihua Zhang Mentor: Orson W. Moe Khashayar Sakhaee Naim M. Maalouf 1 Estrogen and phosphorus, geneJc hypercalcemia and uric acid and bone health Center of Mineral Metabolism and Clinical Research 2 Outline Clinical research : • Estrogen use and serum phosphorus • Serum uric acid and bone mineral density Combined clinical and basic research : • Familial hypocalciuric hypercalcaemia 3 Background • Hyperphosphatemia is associated with vascular calcificaJon and increased cardiovascular morbidity and mortality in chronic kidney disease • Higher serum phosphorus within the normal range is associated with increased cardiovascular morbidity and mortality in the general populaJon. • Higher serum phosphorus and lower urine phosphorus excreJon exist in postmenopausal women. 4 Aims and Methods • The associaJon of estrogen use with serum phosphorus in postmenopausal women. • ParJcipants from NHANES 2003-­‐2006 and kidney stone registry at UTSW. 5 Results: Serum P changes according to gender and age Female Female Male NHANES 2003-2006 Male UTSW stone registry 6 Results: Characteris9cs of postmenopausal women with and without estrogen use 7 Results: Estrogen use and Serum P changes in postmenopausal women 8 Summary In postmenopausal women: • Estrogen use is associated with a decrease in serum phosphorus. • Estrogen status may account for the gender and age difference in serum phosphorus levels. • Estrogen use may modulate CVD risk through changes in serum phosphorus. 9 Outline Clinical research : • Estrogen use and serum phosphorus • Serum uric acid and bone mineral density Combined clinical and basic research : • Familial hypercalcaemia 10 Background • Osteoporosis is an age-­‐related disorders. • Prior studies found some associaJon between plasma uric acid level and bone mineral density (BMD) in postmenopausal women and older men. • Hypothesis was proposed that higher serum uric acid is protecJve against osteoporosis. 11 Aims and Methods • The relaJonship between serum uric acid levels and BMD in general populaJon. • ParJcipants from NHANES 2005-­‐2006. 12 Results: Associa9on of serum uric acid with bone mineral density in women 13 Results: Associa9on of serum uric acid with bone mineral density in men 14 Summary • Cross-­‐secJonal data analyses did not detect associaJon between serum uric acid level and BMD in the general populaJon. • It is premature to conclude that high serum uric acid is protecJve against osteoporosis 15 Outline Clinical research : • Estrogen use and serum phosphorus • Serum uric acid and bone mineral density Combined clinical and basic research : • Familial hypocalciuric hypercalcaemia 16 Background • Familial hypocalciuric hypercalcemia is a rare geneJc disease resulJng from mutaJons in the gene encoding for the calcium sensing receptor. 17 Known mutations of CaSR 18 Aims and Methods • Three paJents presented to the Mineral Metabolism Clinic with a clinical picture compaJble with familial hypocalciuric hypercalcemia • Genotype the CaSR • FuncJonal studies of the CasR mutants 19 S171R A194V I554N 20 Ca induced CaSR acJvity measured by phospho-­‐ERK1/2 formaJon 21 Dose responses of Ca-­‐induced CaSR acJvity measured by p-­‐ERK1/2 : t-­‐ERK1/2 raJo 22 Summary • S171R, A194V in exon 4 and I554N in exon 5 are novel inacJvaJng mutaJons of the CASR gene. • These CASR gene mutaJons causes familial hypocalciuric hypercalcemia . 23 Future work at SYSU Clinician-Clinical investigator Specialty-Hemodialysis Mineral Metabolism Analysis of Clinical Database Basic biochemistry and molecular biology techniques Study mineral disorders in hemodialysis pa9ents. Set up hemodialysis pa9ents Set up enzyme assays for registry . research purpose in HD units. For example: FGF23, Klotho 24 Acknowledgements • • • • Orson W. Moe Khashayar Sakhaee Naim M. Maalouf Beverley Adams-­‐Huet • • • • Ming Chang Hu Jianning Zhang Liping Li Alexandru Bobulescu Supported by Sun Yat-Sun University First Affiliated Hospital-UTSouthwestern Exchange Scholars Program 25